human | Q5 |
P496 | ORCID iD | 0000-0003-2821-0387 |
P108 | employer | University of Essex | Q1075104 |
P735 | given name | Ralf | Q1245713 |
Ralf | Q1245713 | ||
P106 | occupation | researcher | Q1650915 |
Q39924087 | A non-apoptotic role for caspase-9 in muscle differentiation |
Q57384595 | A novel method for the combined flow cytometric analysis of cell cycle and cytochrome c release |
Q40582634 | AAV-encoded expression of TRAIL in experimental human colorectal cancer leads to tumor regression. |
Q44115873 | Adenovirus-mediated manganese superoxide dismutase gene transfer to hamster cheek pouch carcinoma cells. |
Q73444896 | Age-dependent hypertension in Mpv17-deficient mice, a transgenic model of glomerulosclerosis and inner ear disease |
Q28183225 | Aspirin-induced activation of the NF-kappaB signaling pathway: a novel mechanism for aspirin-mediated apoptosis in colon cancer cells |
Q38323803 | Betulinic acid as new activator of NF-kappaB: molecular mechanisms and implications for cancer therapy |
Q39505707 | Both human and mouse mesenchymal stem cells promote breast cancer metastasis. |
Q37369909 | CD4(+) T-lymphocytes mediate ischemia/reperfusion-induced inflammatory responses in mouse liver |
Q53867825 | Caspase-8L expression protects CD34+ hematopoietic progenitor cells and leukemic cells from CD95-mediated apoptosis. |
Q40218268 | Constitutively activated nuclear factor-kappaB, but not induced NF-kappaB, leads to TRAIL resistance by up-regulation of X-linked inhibitor of apoptosis protein in human cancer cells. |
Q36215003 | DR4 specific TRAIL variants are more efficacious than wild-type TRAIL in pancreatic cancer |
Q37073589 | Delivery of sTRAIL variants by MSCs in combination with cytotoxic drug treatment leads to p53-independent enhanced antitumor effects |
Q46872442 | Development of a FACS-based Smac/DIABLO release assay to monitor individual drug responses and to pave the way towards patient-tailored therapies. |
Q51192946 | Effects of antioxidant enzyme overexpression on the invasive phenotype of hamster cheek pouch carcinoma cells. |
Q38611997 | Expression of the recessive glomerulosclerosis gene Mpv17 regulates MMP-2 expression in fibroblasts, the kidney, and the inner ear of mice |
Q34295898 | Functional rescue of the glomerulosclerosis phenotype in Mpv17 mice by transgenesis with the human Mpv17 homologue. |
Q40849028 | Gene therapy for colon cancer. |
Q39439318 | IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells |
Q39541500 | Immunolocalization and adenoviral vector-mediated manganese superoxide dismutase gene transfer to experimental oral tumors |
Q40188536 | In situ trapping of initiator caspases reveals intermediate surprises. |
Q45856291 | Intratracheal injection of adenovirus containing the human MnSOD transgene protects athymic nude mice from irradiation-induced organizing alveolitis. |
Q77355587 | Ischemia/reperfusion injury in the liver of BALB/c mice activates AP-1 and nuclear factor kappaB independently of IkappaB degradation |
Q48553142 | Loss of auditory function in transgenic Mpv17-deficient mice. |
Q33925097 | Manganese superoxide dismutase induces p53-dependent senescence in colorectal cancer cells. |
Q41051027 | Manganese superoxide dismutase protects nNOS neurons from NMDA and nitric oxide-mediated neurotoxicity. |
Q37310677 | Mesenchymal stem cells expressing TRAIL lead to tumour growth inhibition in an experimental lung cancer model |
Q40102576 | MnSOD protects colorectal cancer cells from TRAIL-induced apoptosis by inhibition of Smac/DIABLO release. |
Q45871895 | NF-kappaB kinetics predetermine TNF-alpha sensitivity of colorectal cancer cells |
Q55469625 | NF-kappaB-independent sensitization of glioblastoma cells for TRAIL-induced apoptosis by proteasome inhibition. |
Q37679126 | Overexpression of human catalase inhibits proliferation and promotes apoptosis in vascular smooth muscle cells |
Q43827486 | Overexpression of human superoxide dismutase inhibits oxidation of low-density lipoprotein by endothelial cells. |
Q34467287 | Prevention of late effects of irradiation lung damage by manganese superoxide dismutase gene therapy. |
Q35594351 | Reactive oxygen species in oncogenic transformation |
Q64381763 | Recombinant adenovirus-mediated cardiac gene transfer of superoxide dismutase and catalase attenuates postischemic contractile dysfunction |
Q45887796 | Redox gene therapy for ischemia/reperfusion injury of the liver reduces AP1 and NF-kappaB activation. |
Q41028918 | Redox gene therapy protects human IB-3 lung epithelial cells against ionizing radiation-induced apoptosis |
Q43563087 | Subcellular site of superoxide dismutase expression differentially controls AP-1 activity and injury in mouse liver following ischemia/reperfusion |
Q31825675 | Superoxide anions and endothelial cell proliferation in normoglycemia and hyperglycemia. |
Q39645187 | TRAIL-induced apoptosis is preferentially mediated via TRAIL receptor 1 in pancreatic carcinoma cells and profoundly enhanced by XIAP inhibitors |
Q39649739 | Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells |
Q39862039 | The TRAIL-receptor-1: TRAIL-receptor-3 and -4 ratio is a predictor for TRAIL sensitivity of cancer cells. |
Q37342739 | The enigmatic roles of caspases in tumor development |
Q24336548 | The glomerulosclerosis gene Mpv17 encodes a peroxisomal protein producing reactive oxygen species |
Q34347731 | The human homolog of the glomerulosclerosis gene Mpv17: structure and genomic organization |
Q34738743 | The yeast TEL1 gene partially substitutes for human ATM in suppressing hyperrecombination, radiation-induced apoptosis and telomere shortening in A-T cells |
Q33763851 | Therapeutic approaches for ischemia/reperfusion injury in the liver. |
Q79834427 | Vitamin D3-24-hydroxylase (CYP24) as a potential target for intervention with diabetic and nondiabetic nephropathy |
Q79889958 | [Gene therapy strategies for colorectal cancer] |
Search more.